—

Sanofi SA (SAN.PA) — Technical state

As of 2026-11-16 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 64 out of 100 (momentum 76 · quality 69 · valuation 63), as of 2026-11-18.
  • Signal: New 52-week high — At a fresh 52-week high. (as of 2026-11-16)
  • Trend: Sanofi SA trades 16.4% above its 50-day and 16.7% above its 200-day moving average. (as of 2026-11-16)
  • Index seat: Euro-AI 50

Sanofi researches, develops and manufactures medicines and vaccines, covering immunology, rare diseases, neurology, oncology and other therapeutic areas. Its vaccine business includes childhood shots for polio, pertussis and Hib, plus respiratory syncytial virus protection and combination vaccines against hepatitis, typhoid, yellow fever and rabies.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the SAN.PA overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

New 52-week high

At a fresh 52-week high.

The moving-average stack

FAQ · from the current data · as of 2026-11-16

Quick answers

What is the current Closelooknet signal on SAN.PA?

New 52-week high — At a fresh 52-week high. As of 2026-11-16; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is SAN.PA above its 50-day and 200-day moving averages?

As of 2026-11-16, Sanofi SA trades +16.4% above its 50-day and +16.7% above its 200-day average, with the 20-day +9.5% away.

How far is SAN.PA from its 52-week high?

0.8% below the 52-week high and 26.6% above the 52-week low, as of 2026-11-16.

Related in the Closelooknet universe

same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.